Surveillance of the eye and vision in a clinical trial of MART1-transformed dendritic cells for metastatic melanoma.

@article{Gordon2004SurveillanceOT,
  title={Surveillance of the eye and vision in a clinical trial of MART1-transformed dendritic cells for metastatic melanoma.},
  author={Lynn Gordon and Antoni Ribas and Steven Nusinowitz and Lisa H Butterfield and John A. Glaspy and James Steven Economou and Bradley R. Straatsma},
  journal={Controlled clinical trials},
  year={2004},
  volume={25 4},
  pages={400-7}
}
PURPOSE To report the protocol for surveillance of the eye and vision in a clinical trial of MART1-transduced dendritic cells for metastatic melanoma. METHODS In a phase I/II clinical trial of dendritic cell-based genetic immunotherapy for metastatic cutaneous melanoma, ophthalmic evaluation is performed prior to immunization (Baseline Evaluation), 56+/-7… CONTINUE READING